2m 2m 2m 2m 2m 2m 2m
PROTALIX BIOTHPS (PLX)
NYSE
$1.96$0.00 (0.00%)
Price as of Jun 03, 2026 5:46 PM EDT- $170.0MMarket Cap
- 22.50%1-Year Change
- BiotechnologyIndustry
PROTALIX BIOTHPS (PLX)
$1.96$0.00 (0.00%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 51.8M -2.99% | 53.4M -18.47% | 65.5M +37.48% | 47.6M +24.22% | |
Cost of Revenue | 27.0M +11.00% | 24.3M +5.82% | 23.0M +17.30% | 19.6M +19.84% | |
Gross Profit | 24.8M -14.69% | 29.1M -31.60% | 42.5M +51.58% | 28.0M +27.48% | |
Sales and Marketing Expense | 11.7M -4.19% | 12.2M -18.49% | 15.0M +27.73% | 11.7M -8.00% | |
Research and Development Expense | -19.6M +50.88% | -13.0M -24.12% | -17.1M -41.76% | -29.3M -1.29% | |
Depreciation and Amortization Expense | 1.5M +12.35% | 1.3M +9.49% | 1.2M +9.67% | 1.1M -2.86% | |
Total Operating Expenses | 11.7M -4.19% | 12.2M -18.49% | 15.0M +27.73% | 11.7M -8.00% | |
Operating Profit | -5.5M -240.41% | 3.9M -62.55% | 10.5M +180.37% | -13.0M -36.40% | |
Interest Income | 1.1M -16.63% | 1.3M +1.01% | 1.3M +12.22% | 1.1M +185.79% | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 1.1M -16.63% | 1.3M +1.01% | 1.3M +12.22% | 1.1M +185.79% | |
Total Nonoperating Income and Expense | -108,000 -145.57% | 237,000 +112.51% | -1.9M +36.95% | -1.4M -80.58% | |
Income before Taxes | -5.6M -235.00% | 4.2M -51.51% | 8.6M +159.50% | -14.4M -29.64% | |
Income Taxes | 996,000 -18.49% | 1.2M +381.10% | 254,000 -52.08% | 530,000 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -6.6M -325.24% | 2.9M -64.73% | 8.3M +155.68% | -14.9M -45.88% | |
Net Income from Continuing Operations Applicable to Common | -5.6M -235.00% | 4.2M -51.51% | 8.6M +159.50% | -14.4M -47.80% | |
Basic EPS and Net Income | -0.08 -300.00% | 0.04 -66.67% | 0.12 +138.71% | -0.31 -50.00% | |
Diluted EPS and Net Income | -0.08 -300.00% | 0.04 -55.56% | 0.09 +129.03% | -0.31 -50.00% | |
Basic Weighted Average Shares | 78.5M +8.29% | 72.5M +7.43% | 67.5M +39.28% | 48.5M +9.81% | |
Diluted Weighted Average Shares | 78.5M -3.10% | 81.1M -1.66% | 82.4M +70.04% | 48.5M +9.81% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 14.7M -25.71% | 19.8M -16.39% | 23.6M +38.12% | 17.1M -56.11% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 14.7M -25.71% | 19.8M -16.39% | 23.6M +38.12% | 17.1M -56.11% | |
Total Current Assets | 66.7M +10.98% | 60.1M -14.09% | 69.9M +55.82% | 44.9M -27.22% | |
Accumulated Depreciation | 37.0M +3.66% | 35.7M +3.03% | 34.7M +2.97% | 33.7M +2.85% | |
Property and Plant and Equipment and Net | 4.9M +6.27% | 4.6M -7.68% | 5.0M +9.22% | 4.6M -8.24% | |
Total Long-Term Assets | 4.9M +6.27% | 4.6M -7.68% | 5.0M +9.22% | 4.6M -8.24% | |
Total Assets | 82.3M +12.16% | 73.4M -13.05% | 84.4M +51.35% | 55.8M -24.27% | |
Income Taxes Payable | 3.0M -15.13% | 3.5M +20.86% | 2.9M N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | 0 -100.00% | 20.3M +370.95% | 4.3M -92.65% | |
Total Current Liabilities | 26.5M +3.50% | 25.6M -43.73% | 45.5M +40.40% | 32.4M -2.25% | |
Total Long-Term Debt | N/A N/A | N/A N/A | 28.2M 0.00% | 28.2M +1.08% | |
Total Long-Term Liabilities | 7.6M +65.71% | 4.6M -14.06% | 5.3M -84.31% | 34.0M -26.93% | |
Total Liabilities | 34.1M +12.94% | 30.2M -40.62% | 50.9M -23.43% | 66.4M -16.65% | |
Retained Earnings | -385.0M +1.75% | -378.4M -0.83% | -381.5M -2.13% | -389.9M +3.98% | |
Total Stockholders Equity | 48.2M +11.62% | 43.2M +28.72% | 33.6M +415.50% | -10.6M +76.28% | |
Total Shares Outstanding | 80.4M +6.03% | 75.9M +3.97% | 73.0M +35.62% | 53.8M +18.07% | |
Cash Flow | |||||
Cash from Operating Activities | -12.0M -238.26% | 8.7M +758.12% | -1.3M -94.73% | -25.0M +143.07% | |
Capital Expenditures | 1.6M +27.77% | 1.3M +11.58% | 1.1M +82.96% | 628,000 -56.96% | |
Cash from Investing Activities | -2.4M -156.05% | 4.2M +125.26% | -16.7M +231.90% | -5.0M -126.61% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 9.3M +155.53% | -16.8M -168.09% | 24.7M +199.42% | 8.2M -31.79% | |
Financials Ratio | |||||
Gross Margin | 47.89% -12.06% | 54.46% -16.10% | 64.91% +10.25% | 58.87% +2.62% | |
Operating Margin | -10.62% -244.74% | 7.34% -54.07% | 15.97% +158.46% | -27.32% -48.80% | |
Return on Assets | -8.48% -328.26% | 3.71% -68.67% | 11.86% +151.41% | -23.06% -40.80% | |
Return on Equity | -14.44% -289.13% | 7.64% -89.47% | 72.50% -59.50% | 179.02% +7.33% | |
Revenue Growth | -2.99% -83.81% | -18.47% -149.27% | 37.48% +54.77% | 24.22% +162.05% | |
Current Ratio | 2.51 +7.22% | 2.34 +52.66% | 1.54 +10.99% | 1.38 -25.55% | |
Cash Ratio | 0.55 -28.22% | 0.77 +48.56% | 0.52 -1.61% | 0.53 -55.10% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | 1.44 +147.26% | -3.05 -78.67% | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | 0.57 -1.48% | 0.58 -50.35% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow